It was January 2013, freezing cold, and I was back at my desk in the City with a box of tissues and a mugof Lemsip on the go.

Investing in dividend-paying stocks is one of numerous approaches that can help you maximize your portfolio growth, and ...

Spyre Therapeutics (SYRE) stock analysis: de-risked pipeline, cash runway to H2 2028, and 2026–2027 Phase 2 catalysts in ...

PALI-2108 is the first and only PDE4 inhibitor in development targeting the terminal ileum and colon for treatment of ulcerative colitis (UC) and fibrostenotic Crohn’s disease (FSCD) to address ...

Doctors are seeing colon cancer in people in their 20s and 30s. New research suggests it starts in infancy.

Crohn’s disease is a poorly understood autoimmune reaction that causes inflammation of the gastrointestinal tract. Here's ...

Abivax (ABVX) stock surged on Obefazimod trial success and takeover rumors. Learn if valuation risks now outweigh reward.

Learn about common early signs of ulcerative colitis, including blood in stool, diarrhea, cramping, bloating, and bowel changes, for a prompt diagnosis and effective treatment.

U.S. President Donald Trumphas signed an executive order demanding a speedy reclassification of marijuana that would ease ...

Psychologist Melissa Hunt and gastroenterologist Chung Sang Tse and colleagues have found that cognitive behavioral therapy ...

Ulcerative Colitis Pipeline Insight – 2025 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key ...

The ulcerative colitis market is experiencing steady growth driven by rising disease prevalence and increasing diagnosis rates worldwide. Expanding adoption of advanced biologics, small-molecule ...